. . .
.

A week after the Aceon purchase, on May 11, Solvay acquired Teveten tablets from SmithKline Beecham. Teveten already is on the market in Germany, Ireland, Denmark, Finland and the Netherlands. This type of drug represents 10 percent of the anti-hypertensive market worldwide. It received FDA approval in 1997... On May 5, Solvay purchased Aceon tablets, a type of medicine that accounts for 28 percent of the anti-hypertensive market in the country, from Servier SA in France... ..

.:journal ... faq ... webcam ... geocaching ... links ... contact:.

 

 

 

 

 

.
.
.
.